Effective anti-TNF-α therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis

Journal of Rheumatology

Volumn 36, Issue 11, 2009, Pages 2409-2415

  Kuroda, Takeshi ^a   Wada, Yoko ^a   Kobayashi, Daisuke ^a   Murakami, Shuichi ^a   Sakai, Takehito ^b   Hirose, Shintaro ^c   Tanabe, Naohito ^a   Saeki, Takako ^d   Nakano, Masaaki ^e   Narita, Ichiei ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Niigata Rheumatic Center   (Japan)

^c Saiseikai Niigata Daini Hospital   (Japan)

^d NAGAOKA RED CROSS HOSPITAL   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

Author keywords

Amyloidosis; Gastroduodenal biopsy; Rheumatoid arthritis; Tumor necrosis factor inhibitor

Indexed keywords

C REACTIVE PROTEIN; CREATININE; ETANERCEPT; INFLIXIMAB; SERUM AMYLOID A;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BACTERIAL INFECTION; CELLULITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DETERIORATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DUODENUM BIOPSY; FEMALE; HERPES ZOSTER; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; RHEUMATOID ARTHRITIS; STOMACH BIOPSY; TREATMENT DURATION; URINARY EXCRETION;

ADULT; AGED; AMYLOID; AMYLOIDOSIS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; DUODENUM; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 70450171028     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090101     Document Type: Article

References (44)

1. Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischemic heart disease and in pulmonary fibrosis. Rheumatology 2007;46:350-357
2. Baecklund E, Lliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692-701.
3. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-732 (Pubitemid 40365093)
4. Watson DJ, Rhodes T, Guess HA. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 2003;30:1196-1202 (Pubitemid 36666340)
5. Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 1991;70:246-256
6. Gillmore JD, Lovat L, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid protein. Lancet 2001;358:24-29 (Pubitemid 32709735)
7. Husby G, Marhaug F, Dowton B, Sletten K, Sipe JD. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid 1994;1:119-137 (Pubitemid 2100716)
8. Cunnane G, Whitehead AS. Amyloid precursors and amyloidosis in rheumatoid arthritis. Baillieres Clin Rheumatol 1999;13:615-628 (Pubitemid 30050431)
9. Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996;35:44-49 (Pubitemid 126433749)
10. El Mansoury TM, Hazenberg BP, El Badawy SA, Ahmed AH, Bijzet J, Limburg PC, et al. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis 2002;61:42-47 (Pubitemid 34074838)
11. Wakhlu A, Krisnani N, Hissaria P, Aggarwal A, Misra R. Prevalence of secondary amyloidosis in Asian North Indian patients with rheumatoid arthritis. J Rheumatol 2003;30:948-951 (Pubitemid 36529612)
12. Husby G. Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 1985;3:173-180
13. Kuroda T, Tanabe N, Sakatsume M, Nozawa S, Mitsuka T, Ishikawa H, et al. Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis. Clin Rheumatol 2002;21:123-128 (Pubitemid 34649593)
14. Carmona L, Gonzalez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmarti R. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis 2003;62:897-900. (Pubitemid 37026504)
15. Misra R, Wakhlu A, Krishnani N, Hissaria P, Aggarwal A. Prevalence of silent amyloidosis in rheumatoid arthritis and its clinical significance. J Rheumatol 2004;31:1031-1034
16. Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Shono M, Baba S. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Rheumatol 2003;22:371-375 (Pubitemid 41510436)
17. Chevrel G, Jenvrin C, McGregor B, Miossec P. Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology 2001;40:821-825 (Pubitemid 32717075)
18. Maezawa A, Hiromura K, Mitsuhashi H, Tsukada Y, Kanai H, Yano S, et al. Combined treatment of cyclophosphamide and prednisolone can induce remission of nephritic syndrome in a patient with renal amyloidosis, associated with rheumatoid arthritis. Clin Nephrol 1994;42:30-32 (Pubitemid 24215997)
19. Komatsuda A, Morita K, Ohtani H, Yamaguchi A, Miura AB. Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate. Am J Kidney Dis 1998;32:E7.
20. Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, Irimajiri S, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 1994;21:33-36 (Pubitemid 24044913)
21. Joss N, McLaughlin K, Simpson K, Boulton-Jones JM. Presentation, survival and prognostic markers in AA amyloidosis. Q J Med 2000;93:535-542 (Pubitemid 30627402)
22. Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol 2003;21:343-346 (Pubitemid 36747830)
23. Okuda Y, Takasugi K, Oyama T, Oyama H, Nanba S, Miyamoto T. Intractable diarrhea associated with secondary amyloidosis in rheumatoid arthritis. Ann Rheum Dis 1997;56:535-541 (Pubitemid 27428476)
24. Kuroda T, Tanabe N, Harada T, Murakami S, Hasegawa H, Sakatsume M, et al. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol 2006;25:498-505. (Pubitemid 44137623)
25. Elkayam O, Hawkins PN, Lachmann H, Yaron M, Caspi D. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum 2002;46:2571-2573 (Pubitemid 36118918)
26. Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, et al. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides. Arthritis Rheum 2003;48:2019-2024
27. Smith GR, Tymms KE, Falk M. Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis. Intern Med J 2004;34:570-572 (Pubitemid 39482333)
28. Okuda Y, Takasugi K. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum 2006;54:2997-3000. (Pubitemid 44497781)
29. Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Exp Rheumatol 2007;25:518-522 (Pubitemid 47455459)
30. Kuroda T, Otaki Y, Sato H, Fujimura T, Nakatsue T, Murakami S, et al. A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with infliximab. Rheumatol Int 2008;28:1155-1159
31. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
32. Kuroda T, Tanabe N, Sato H, Ajiro J, Wada Y, Murakami S, et al. Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment. Rheumatol Int 2006;26:1147-1153 (Pubitemid 44450853)
33. Nakamura T. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis. Mod Rheumatol 2008;18:109-118
34. Nakano M, Ueno M, Nishi S, Shimada H, Hasegawa H, Watanabe T, et al. Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clin Nephrol 1998;50:154-160 (Pubitemid 28434743)
35. Sanai T, Nanishi F, Nagata M, Hirano T, Suematsu E, Esaki Y, et al. Role of amyloidosis in determining the prognosis of dialyzed patients with rheumatoid arthritis. Rheumatol Int 2007;27:363-367 (Pubitemid 46122280)
36. Immonen K, Finne P, Hakala M, Kautiainen H, Pettersson T, Gronhagen-Riska C. No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases - data from the Finnish national registry for kidney diseases. J Rheumatol 2008;35:1334-1338 (Pubitemid 352000780)
37. Nishi S, Alchi B, Imai N, Gejyo F. New advances in renal amyloidosis. Clin Exp Nephrol 2008;12:93-101.
38. Sugioka Y, Inui K, Koike T. Use of etanercept in a patient with rheumatoid arthritis on hemodialysis. Mod Rheumatol 2008;18:293-295
39. Maini R, St. Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT Study Group. Lancet 1999;354:1932-1939.
40. Breedveld FC, Markusse HM, MacFarlane JD. Subcutaneous fat biopsy in the diagnosis of amyloid secondary to chronic arthritis. Clin Exp Rheumatol 1989;7:407-410 (Pubitemid 19248581)
41. Sorsa S, Happonen RP, Klemi P. Oral biopsy and fine needle aspiration biopsy from subcutaneous fat in diagnosis of secondary amyloidosis. Int J Oral Maxillofac Surg 1988;17:14-16 (Pubitemid 18069888)
42. Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, et al. A novel allelic variant of serum amyloid A, SAA1?: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet 1995;4:1083-1087
43. Ajiro J, Narita I, Sato F, Saga D, Hasegawa H, Kuroda T, et al. SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis. Mod Rheumatol 2006;16:294-299 (Pubitemid 44575255)
44. Hasegawa H, Nishi S, Ito S, Saeki T, Kuroda T, Kimura H, et al. High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis. Arthritis Rheum 1996;39:1728-1732 (Pubitemid 26331027)